GtreeBNT receives approval from FDA for phase 3 clinic trial for GBT-201/RGN-259
Date
2015-08-25
GtreeBNT receives approval from FDA for phase 3 clinic trial for GBT-201/RGN-259
(if you want to view the body of article, click on the bottom link)
http://www.reuters.com/finance/stocks/115450.KQ/key-developments/article/3265171
(if you want to view the body of article, click on the bottom link)
http://www.reuters.com/finance/stocks/115450.KQ/key-developments/article/3265171